InvestorsHub Logo
Post# of 4210
Next 10
Followers 49
Posts 4134
Boards Moderated 0
Alias Born 05/20/2014

Re: None

Monday, 08/24/2020 11:25:41 PM

Monday, August 24, 2020 11:25:41 PM

Post# of 4210
Here is some due diligence:$OMHE

cheers,
ticker symbol: $OMHE

entity name: OMNIHEALTH, INC

relivatrol physician endorsement: https://www.dailymotion.com/relivatrol/videos?sort=visited

relivatrol study with larger ones underway:
https://insights.ovid.com/obstetrics-gynecology/obsgy/2020/05/001/novel-therapeutic-management-post-episiotomy-pain/475/00006250

CONCLUSION:
We concluded that Relivatrol© significantly decreases post-episiotomy pain. Being a pilot study had multiple limitations; we developed a protocol for a larger investigation and are currently collecting data involving a greater number of subjects, a control arm, pharmacokinetic parameters, and an analysis of quality of life impact.



MY 35+ PAGE DUE DILIGENCE PACKET:
OMNIHEALTH, INC DUE DILIGENCE

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.